Mental health.
Conditions
Interventions
Intervention 1: Intervention group: Each patient is given 1 pack of 30 melatonin tablets( 3 mg) manufactured by Razak Company for up to 2 months based on the allocation. To prevent sample loss, they a
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Women aged 40 to 60 years old, based on self-reported data Total cessation of menstruation for at least 12 months.
Exclusion criteria
Exclusion criteria: Consumption of vitamin supplements, soy-containing supplements, or use of hormone therapy within the past 3 months. Use of sedative or antidepressant medications, sleep aids, or antihypertensive drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score on the DAS questionnaire. Timepoint: Measurement of depression score before the intervention, 4 and 8 weeks after starting melatonin tablets. Method of measurement: DASS 21- Questionnaire.;Anxiety score on the DAS questionnaire. Timepoint: Measurement of anxiety score before the intervention, 4 and 8 weeks after starting melatonin tablets. Method of measurement: DASS 21- Questionnaire.;Stress score on the DAS questionnaire. Timepoint: Measurement of stress score before the intervention, 4 and 8 weeks after starting melatonin tablets. Method of measurement: DASS 21- Questionnaire.;Goldberg General Health Questionnaire. Timepoint: Measurement of general health score before the intervention, 4 and 8 weeks after starting melatonin tablets. Method of measurement: Goldberg General Health Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNehleh Parandavar
Jahrom University of Medical Sciences
Outcome results
None listed